Navigation Links
Transporter offers reliable clues for safer pain medicine

Researchers have zeroed in on a transporter that actually quietens the body’s natural pain killers. This discovery will show the way for potent and non-habit //forming pain killers and will help perceive the pain threshold of AIDS patients.

Opioid peptides are natural pain relievers with receptors – first identified because they react to opium – throughout the body, says Dr. Vadivel Ganapathy, chair of the Department of Biochemistry and Molecular Biology at the Medical College of Georgia. Studies have shown, for example, opioid peptide levels increase during childbirth.

Many potent pain killers, such as morphine and codeine, override this natural pain control system by directly activating opioid peptide receptors. While pain control is effective, it comes at a price: potential addiction, immune suppression and constipation.

Now researchers want to know whether safer pain killers can be developed that augment the body’s natural pain-killing ability by targeting instead the opioid peptide transport system that terminates pain-control communication, says Dr. Ganapathy. 'This has the potential for non-addictive pain killers that are effective, but by a different mechanism.'

Many popular antidepressants work in a similar fashion to keep the body’s natural chemical messengers, called neurotransmitters, working longer by keeping them from being taken back up into the neuron by transport systems. Chemical messengers are supposed to have limited action, he says. But depressed patients have insufficient levels of chemicals for adequate communication between neurons. Antidepressants provide more mileage from existing neurotransmitters.

Dr. Ganapathy hopes to do the same with endogenous pain killers. Armed with a two-year, $286,000 grant from the National Institute on Drug Abuse, he is working to clone the opioid peptide transporter he identified three years ago and identify the responsible gene and protein.


'"/>




Page: 1 2 3

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Magnesium sulfate offers no help in migraine treatment
4. ESRC offers new dynamics for old in UK
5. Roche offers HIV drug expertise to poor nations
6. Genetically modified Lactic acid bacteria offers HIV protection
7. SRL Ranbaxy offers quicker bird flu diagnostic test
8. Victorian Initiative: Coffers Are Ringing For an Upcoming Cancer Agency
9. Kidney Disease Is Milking the Government Coffers - Is Australia Notorious for High Rates of Kidney Disease?
10. Fermented Milk offers protection against allergies in infants
11. Tegaserod offers relief for Chronic Constipation
Post Your Comments:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
... study researchers say hunger may be associated wi...searchers // studied 16 men who agreed to skip bre...previous evening. Participants were asked to consu... the flavor they tasted. The participants did not ...
...t that a chemical called parthenolide is successfu...s found// in a widely available plant of North Ame...or centuries to treat migraine and rheumatoid arth...s being linked to blood cancer research. Past stu...
... study by researchers, brain stimulation may help ...ent do not show any result on them. People suffer...d reacted positively to stimulation of their brain...g. Electrodes surgically planted in that part of t...
...ournal Of Clinical Investigations show that certai...ssociated herpes virus (KSHV) that can cause cance...or total recovery. KSHV is a form of herpes virus...ed in the infected cells of the affected person. N...
Other Medicine News:
(Date:9/4/2008)...The Lancet, and Presented at ESC Congress-, PHILA...w international,study, the GISSI Heart Failure (GI...cid ethyl esters reduced all cause mortality and h...atients with chronic heart,failure. These findings...he,Lancet, and were presented at the European Card...
(Date:9/4/2008)...l Data for Ipilimumab to be Presented, PRINCETON,...Inc.,(Nasdaq: MEDX ) announced today that nine cl...l anti-CTLA-4 antibody, in melanoma are scheduled ...gress of the European Society,for Medical Oncology...olm.,Many of the following abstracts will include ...
(Date:9/3/2008)... Asked. Wrong Children Studied. Wrong,Conclusions ...re/ -- A Centers for Disease,Control and Preventio...nk,between the MMR vaccine and autism. The Nationa...thing to dispel the growing public concern over a,...ions concerning design,and methodology., For year...
(Date:9/3/2008)...ENEVA, Sept. 3 /- Artelis SA and,Sele...d monoclonal antibody,production with the achievem...iter. This record level was accomplished by applyi...performance stable Selexis CHO,production cell lin... at,Selexis SA using their proprietary Selexis Gen...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3CDC Misses Target With Flawed MMR/Autism Study 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Stallergenes 3A Q2 2008 Sales up 18 25 Revision Upwards of 2008 Sales Growth 6493 1Stallergenes 3A Q2 2008 Sales up 18 25 Revision Upwards of 2008 Sales Growth 6493 2Link shown between thunderstorms and asthma attacks in metro Atlanta area 23729 1Link shown between thunderstorms and asthma attacks in metro Atlanta area 23729 2Link shown between thunderstorms and asthma attacks in metro Atlanta area 23729 3Melanoma Rates Soar Among Younger Women 23727 1Melanoma Rates Soar Among Younger Women 23727 2Melanoma Rates Soar Among Younger Women 23727 3Kidney Community Applauds Senate for Passage of End Stage Renal Disease 28ESRD 29 Improvements 23725 1Kidney Community Applauds Senate for Passage of End Stage Renal Disease 28ESRD 29 Improvements 23725 2
...ORD, Conn.--(BUSINESS WIRE)--Jun 25, 2007 - Neurog...tive top-line,results from two dose-ranging, Phase...ith the Company,s proprietary insomnia agent,NG2-... Multiple,formulations were studied in each trial ...p onset and maintenance of sleep,through the night...
...OUTH MEETING, Pa., June 25, 2007 /PRNewswire-First...data from a preclinical,study of trodusquemine (MS...d during the American Diabetes Association (ADA) 6.... Dr. Kristen Lantz,Genaera research scientist an...dusquemine is a Multiple Pathway Inhibitor that,Ca...
Other Medicine Technology:Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 2Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 3Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 4Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 5Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 6Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 7Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 8Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 2Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 3Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 4
The MD Coder is simply more than a reference guide: it is a handheld solution for accurate coding and patient tracking for both individual physicians and small practice groups. MD Coder v6.0 now come
Integrated patient tracking and billing. This product contains the complete Handheld application, a complete Desktop application, and complete CPT™ and ICD-9-CM codes licensed from the AMA. Desi
PharmD ToolBox is an advanced medical calculator and rapid reference for Emergency, Pediatric Dosing and Critical Care for PharmDs. This product is a logical complement to other PDA reference product
iFacts™ is the handheld version of Drug Interaction Facts, a drug interaction analyzer covering thousands of brand and generic drugs. iFacts™ enables the practitioner to refer to accurate a
Medicine Products: